Vitality Plus

•       Supports skin firmness and hydration — Estriol may help restore collagen and moisture in skin affected by declining estrogen, research suggests. ¹

•       Reduces the appearance of fine lines and wrinkles — Tretinoin is among the most well-studied topical anti-aging ingredients; clinical evidence indicates it can visibly improve skin texture and smooth the surface over time. ²

•       May help address hair follicle thinning near the scalp margin and temples — Finasteride reduces DHT, the hormone most associated with androgenic hair thinning, and early studies on topical finasteride suggest local benefits with lower systemic exposure. ³

•       Brightens and evens skin tone — Niacinamide has been shown in multiple studies to reduce hyperpigmentation and dark spots, supporting a more uniform complexion. ⁴

•       Strengthens the skin’s protective barrier — Niacinamide helps reinforce the outermost layer of the skin, which may reduce sensitivity and improve resilience against environmental stress. ⁴

•       Encourages healthy cell turnover — Tretinoin speeds the shedding of older skin cells and stimulates the growth of new ones, which may improve texture and help fade discoloration. ²

•       Addresses multiple concerns with a single product — By combining hormonal, retinoid, anti-androgen, and vitamin B3 activity in one cream, Vitality Plus may offer broader support than single-ingredient treatments. ⁵

•       Some patients report reduced scalp-area skin changes — The anti-androgenic effect of topical finasteride may support skin health in areas prone to DHT-driven changes, though individual results vary. ³

Potential Side Effects

The following side effects may occur with one or more of the active ingredients in this cream. Most are mild and tend to improve as the skin adjusts to treatment:

•       Redness, dryness, or peeling — most common in the first few weeks due to tretinoin; typically improves with continued use ²

•       Skin irritation, stinging, or a warm sensation, especially in those with sensitive skin

•       Increased sun sensitivity — tretinoin makes the skin more vulnerable to UV damage; daily SPF use is strongly recommended ²

•       Temporary skin darkening before brightening — some individuals experience this during the initial adjustment period with tretinoin

•       Localized flaking, tightness, or itching at the application site

•       Mild potential hormonal effects from estriol — systemic absorption from topical estrogen is generally considered low at compounded doses, but should be discussed with the provider ⁶

•       Potential for systemic finasteride absorption — while topical finasteride is associated with lower systemic levels than oral forms, some absorption may occur; this is especially relevant for individuals of childbearing potential ³

•       Changes in skin texture or tone — these are often signs the cream is working, but should be discussed with the provider if concerning or prolonged

Warnings & Precautions

•       Introduce the cream gradually — starting with every other evening for the first few weeks can help the skin adjust and reduce early irritation

•       Avoid contact with the eyes, mouth, nostrils, and broken or sunburned skin

•       Apply broad-spectrum sunscreen (SPF 30 or higher) every morning when using this cream

•       Do not use on inflamed, windburned, or otherwise compromised skin

•       Inform the provider of all other skincare products in use — certain ingredients (e.g., other retinoids, strong acids, benzoyl peroxide) may increase irritation

•       Women of childbearing potential should use effective contraception while using this cream due to the presence of both finasteride and estriol

•       Use under the supervision of a licensed provider experienced with hormonal and anti-androgenic topical therapy

•       Store as directed, typically in a cool, dry place away from direct light and heat

Contraindications

•       Known allergy or sensitivity to any active ingredient (estriol, finasteride, tretinoin, or niacinamide)

•       Pregnancy — finasteride is a Category X medication and must not be used by pregnant individuals or those who may become pregnant; tretinoin also carries risk in pregnancy

•       Breastfeeding — consult the prescribing provider before use

•       Personal or family history of hormone-sensitive cancers (e.g., breast or uterine cancer) — discuss risk versus benefit with the provider before use

•       Liver disease — finasteride is metabolized by the liver; use only with provider guidance

•       Active skin conditions (e.g., eczema, rosacea, psoriasis) in the treatment area — use only with explicit provider approval

•       Use in children or adolescents is not indicated

Drug Interactions

Vitality Plus Cream may interact with other topical or systemic medications and supplements. Patients should share a complete list of all products they are using with their provider and pharmacist. Key interactions to be aware of include:

•       Other retinoids (topical or oral, including isotretinoin) — combining with tretinoin may significantly increase irritation and peeling ²

•       Hormonal medications (oral contraceptives, systemic hormone replacement, other topical estrogens) — concurrent use with estriol should be reviewed to avoid cumulative hormonal exposure ⁶

•       Other 5-alpha reductase inhibitors (e.g., oral finasteride, dutasteride) — combining systemic and topical anti-androgens may amplify effects and side effects ³

•       Strong exfoliants (AHAs, BHAs, benzoyl peroxide) — these may intensify skin irritation when used alongside tretinoin and should be used with caution or avoided ⁷

•       Photosensitizing medications (certain antibiotics, diuretics, or acne treatments) — using these alongside tretinoin may increase sun sensitivity beyond what either product causes alone

Vitality Plus Cream is designed to work on several skin concerns at the same time, using four ingredients that each have a different mechanism of action. Think of it like a four-person team, with each member assigned to a specific job — together, they tackle more than any one of them could alone.

Estriol is a mild form of estrogen that binds to estrogen receptors in the skin. As estrogen levels naturally decline with age — particularly around menopause — skin often becomes thinner, drier, and less firm. Applying estriol topically may help restore some of that support by stimulating collagen production and improving the skin’s ability to retain moisture. ¹ Because estriol is considered the gentlest of the naturally occurring estrogens, it is commonly chosen for topical use where a lower-potency option is preferred. ⁶

Finasteride works by blocking an enzyme called 5-alpha reductase, which converts testosterone into dihydrotestosterone (DHT). DHT is the main hormone responsible for shrinking hair follicles in people with androgenic alopecia — the kind of thinning that follows a pattern around the temples or crown. ³ When applied topically, finasteride may reduce DHT locally in the skin and follicles while limiting the systemic absorption associated with oral finasteride. Early research on topical finasteride suggests it can achieve meaningful local DHT reduction, though the evidence base is still growing.

Tretinoin accelerates the skin’s natural cell renewal cycle. Think of it like a renovation crew that clears out worn-out materials and brings in fresh ones at a faster pace. This process can reduce the look of fine lines, improve uneven texture, and help fade areas of discoloration over time. ² Tretinoin also stimulates collagen production in the deeper layers of the skin, contributing to a firmer, smoother surface with consistent use.

Niacinamide (vitamin B3) rounds out the formulation by supporting the skin’s outer protective barrier and helping to regulate uneven pigmentation. Research shows it may reduce the transfer of pigment to the upper layers of the skin, explaining its brightening effect. ⁴ It also has mild anti-inflammatory properties, which can help reduce redness and improve the overall tolerability of the formulation — particularly helpful alongside tretinoin, which can be initially irritating.

Q: What makes Vitality Plus Cream different from a regular anti-aging cream?

A: Vitality Plus Cream is not a cosmetic — it is a prescription compounded medication. It combines four active pharmaceutical ingredients that work through different pathways in the skin: hormonal support (estriol), anti-androgen activity (finasteride), cell renewal (tretinoin), and barrier brightening (niacinamide). Most over-the-counter products do not include any of these at therapeutic levels. This is a personalized preparation made specifically for each patient based on their provider’s assessment.

Q: Who is this cream typically prescribed for?

A: This cream is often prescribed for adults who are experiencing a combination of skin aging-related changes — such as thinning skin, fine lines, and uneven tone — along with androgenic changes like hair thinning near the temples or scalp margin. Providers may consider it for patients where the interaction between hormones, DHT activity, and general skin aging suggests a multi-ingredient approach may be more effective than treating each concern separately.

Q: How long will it take to see results?

A: Results with this type of formulation take time and consistency. Some patients notice improvements in skin hydration and texture within a few weeks, but meaningful changes in fine lines, tone, and hair follicle health typically take 8 to 12 weeks or longer. Tretinoin in particular is known for a temporary adjustment period — early redness or peeling is common and usually settles down. Finasteride generally requires several months of consistent use before hair-related effects become apparent.

Q: Is it normal to have some redness or peeling at first?

A: Yes — mild redness, flaking, or dryness in the first few weeks is common when starting a tretinoin-containing product. This is sometimes called the ‘retinization’ period and usually resolves as the skin adapts. Using the cream every other evening initially, keeping the skin moisturized, and avoiding other harsh products can help manage this transition. If irritation is significant or does not improve, the prescribing provider should be contacted.

Q: Is this cream safe to use if I am trying to get pregnant?

A: No — this cream is not appropriate for use during pregnancy or while trying to conceive. Finasteride is classified as a Category X medication, meaning it poses serious risk to a developing fetus. Tretinoin is also contraindicated in pregnancy. Patients who are pregnant, planning to become pregnant, or breastfeeding should inform their provider before use and should not apply this product.

Q: Is this an FDA-approved medication?

A: Vitality Plus Cream is a compounded medication, which means it is custom-prepared by a licensed compounding pharmacy and is not an FDA-approved finished drug product. The individual ingredients have varying levels of clinical research behind them, but the specific combination has not undergone FDA review for safety, effectiveness, or quality. Compounded medications are made based on individual provider prescriptions and are subject to pharmacy oversight, not FDA drug approval.

Q: Do I need to do anything special while using this cream?

A: Yes — a few habits make a meaningful difference. Applying sunscreen every morning is essential, since tretinoin increases sun sensitivity. Starting with every other evening use (before moving to nightly) helps the skin adjust. Avoiding other strong skincare actives during the adjustment period is also recommended. Regular follow-up with the prescribing provider allows for monitoring and any needed adjustments to the formulation or frequency.

IMPORTANT INFORMATION ABOUT COMPOUNDED MEDICATIONS

This medication has been compounded (custom-prepared) by a pharmacy. Compounded medications are specially prepared for individual patient needs based on a valid prescription and, as such, are not reviewed or approved by the U.S. Food and Drug Administration (FDA) for safety or efficacy. These statements have not been evaluated by the FDA.

This compounded preparation:

• Has not been approved by the FDA
• Has not undergone FDA review for safety, effectiveness, or quality
• Is prepared specifically for you based on your prescriber's order
• Individual outcomes may vary

Dosing is determined by the prescribing provider based on patient-specific factors. Always follow your healthcare provider's instructions. Compounded medications are not subject to FDA approval and lack the same safety and efficacy data as FDA-approved commercial medications. This medication should be prescribed and monitored by a licensed healthcare professional familiar with the condition being addressed and the specific applications of the medication.

1.    Brincat MP, Baron YM, Galea R. Estrogens and the skin. Climacteric. 2005;8(2):110–123. doi:10.1080/13697130500118100

2.    Kligman AM, Grove GL, Hirose R, Leyden JJ. Topical tretinoin for photoaged skin. J Am Acad Dermatol. 1986;15(4 Pt 2):836–859. doi:10.1016/s0190-9622(86)70242-9

3.    Piraccini BM, Blume-Peytavi U, Scarci F, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. J Eur Acad Dermatol Venereol. 2022;36(2):286–294. doi:10.1111/jdv.17738

4.    Gehring W. Nicotinic acid/niacinamide and the skin. J Cosmet Dermatol. 2004;3(2):88–93. doi:10.1111/j.1473-2130.2004.00115.x

5.    Draelos ZD. Cosmetic formulation of skin care products. Cosmetic Science and Technology Series. Taylor & Francis; 2006.

6.    Callens A, Vaillant L, Lecomte P, et al. Does hormonal skin aging exist? A study of the influence of different hormone therapy regimens on the skin of postmenopausal women using non-invasive measurement techniques. Dermatology. 1996;193(4):289–294. doi:10.1159/000246268

7.    Leyden JJ, Rawlings AV (eds). Skin Moisturization. Marcel Dekker; 2002. (General reference for retinoid skin tolerability and barrier interactions.)

8.    Varothai S, Bergfeld WF. Androgenetic alopecia: an evidence-based treatment update. Am J Clin Dermatol. 2014;15(3):217–230. doi:10.1007/s40257-014-0077-5

9.    Walling M, Roe A. Vulvovaginal atrophy and the topical use of estriol: an overview of current evidence. Post Reprod Health. 2016;22(2):57–63. doi:10.1177/2053369116638098